News - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

92 to 116 of 1009 results

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets

23-01-2014

Indian biotech firm Biocon has entered into an exclusive licensing agreement for US cancer drug developer…

AdvaxisADXS-HPVAsia-PacificBioconIndiaLicensingOncologyPharmaceuticalWomen's Health

Norgine and Kissei’s Savene approved in Japan

21-01-2014

Independent Dutch firm Norgine and its Japanese partner Kissei Pharmaceutical received approval from…

Asia-PacificKissei PharmaceuticalNorgineOncologyPharmaceuticalRegulationSavene

Japanese approval for Bayer’s riociguat for CTEPH

Japanese approval for Bayer’s riociguat for CTEPH

20-01-2014

German pharma major Bayer has received approval from the Ministry of Health, Labor and Welfare for riociguat,…

AdempasAsia-PacificBayerPharmaceuticalRegulationRespiratory and Pulmonaryriociguat

Growing Indian pharma market provides incentives for foreign acquisitions

20-01-2014

A recent IMS Institute for Healthcare Informatics global study has revealed that greater access to medicines…

Asia-PacificIndiaMarkets & MarketingMergers & AcquisitionsPharmaceutical

Astellas gains Japanese clearance for diabetes drug Suglat

Astellas gains Japanese clearance for diabetes drug Suglat

20-01-2014

Japanese drug major Astellas Pharma has obtained the marketing approval of selective SGLT2 inhibitor…

Asia-PacificAstellas PharmaDiabetesipragliflozinKotobuki PharmaceuticalMerck & CoPharmaceuticalRegulationSuglat

Indian government proceeds with FDI policy, despite warnings

Indian government proceeds with FDI policy, despite warnings

20-01-2014

Overlooking concerns about the scarcity of generic drugs in the domestic market given the spate of multinationals…

Asia-PacificIndiaMergers & AcquisitionsPharmaceuticalPolitics

Alvogen takes 67% stake in Lotus Pharma

17-01-2014

Privately-owned US generics firm Alvogen revealed that, last month, it agreed to become the majority…

AlvogenAsia-PacificGenericsLotus PharmaceuticalsMergers & Acquisitions

Celltrion’s trastuzumab biosimilar, Herzuma, approved in South Korea

16-01-2014

South Korean biopharmaceutical firm Celltrion has received approval for its cancer treatment biosimilar…

Asia-PacificBiosimilarsCellTrionGenericsHerceptinHerzumaOncologyRegulationRoche

Tivicay set to become leading HIV treatment by 2016

Tivicay set to become leading HIV treatment by 2016

15-01-2014

Antiretroviral drug Tivicay (dolutegravir) is set to become the leading integrase inhibitor for the treatment…

Anti-viralsAsia-PacificEuropeIsentressJanssenMarkets & MarketingMerck & CoPharmaceuticalPrezistaTivicayUSAViiV Healthcare

Takeda to sell BIKEN varicella vaccine in Japan

Takeda to sell BIKEN varicella vaccine in Japan

15-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical says it has reached agreement with the Research Foundation…

Asia-PacificMarkets & MarketingPharmaceuticalTakeda PharmaceuticalsVaccines

Galena Biopharma links with and Dr Reddy's for NeuVax in India

14-01-2014

USA-based Galena Biopharma and India’s second-largest drugmaker Dr Reddy's Laboratories have entered…

Asia-PacificDr Reddy's LaboratoriesGalena BioPharmaIndiaLicensingNeuVaxOncologyPharmaceutical

Sinopharm executives face corruption probe in China

14-01-2014

China's largest drug distributor, state-owned Sinopharm, has become the most high profile domestic group…

Asia-PacificChinaLegalMarkets & MarketingPharmaceuticalSinopharm

2014: A new dawn for pharma?

2014: A new dawn for pharma?

10-01-2014

We take a look at the week's top stories.

Asia-PacificManagementNovartisPharmaceuticalTeva Pharmaceutical IndustriesUK

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

10-01-2014

Swiss drug major Novartis faced two problems yesterday, when the Japanese Ministry of Health Labor and…

Asia-PacificCardio-vascularDiovanExjadeHematologyLegalMarkets & MarketingNorth AmericaNovartisPharmaceuticalUSA

Lung cancer treatment takes another forward step in New Zealand

Lung cancer treatment takes another forward step in New Zealand

09-01-2014

Improvements in lung cancer treatment are set to continue with a decision for New Zealand’s Pharmaceutical…

Asia-PacificAstraZenecaFinancialHealthcareIressaOncologyPharmaceuticalRocheTarceva

Allergan closes $65 million deal with Medytox

Allergan closes $65 million deal with Medytox

09-01-2014

This week US drugmaker Allergan (NYSE: AGN) announced that it has closed a $65 million license agreement…

AllerganAsia-PacificBotoxDermatologicalsLicensingMedytoxPharmaceuticalRegulationUKUSA

Report: India’s strong commercial opportunities hampered by bureaucracy and poor policy planning

Report: India’s strong commercial opportunities hampered by bureaucracy and poor policy planning

09-01-2014

Due to its large population and substantial unmet medical needs, India represents a market with strong…

Asia-PacificIndiaMarkets & MarketingPharmaceuticalPricingRegulation

Takeda's vedolizumab enters Ph III in Japan for UC and Crohn's disease

Takeda's vedolizumab enters Ph III in Japan for UC and Crohn's disease

08-01-2014

Japan’s largest drugmaker Takeda Pharmaceutical revealed today that vedolizumab), an investigational…

Asia-PacificGastro-intestinalsPharmaceuticalResearchTakeda Pharmaceuticalsvedolizumab

Daiichi Sankyo submits edoxaban application to the EMA for stroke prevention

Daiichi Sankyo submits edoxaban application to the EMA for stroke prevention

08-01-2014

Japanese drug major Daiichi Sankyo (TYO: 4568) has submitted a Marketing Authorization Application to…

Asia-PacificCardio-vascularDaiichi SankyoedoxabanPharmaceuticalRegulation

New Zealand to fully subsidize Abbott Lab’s Ferrograd

New Zealand to fully subsidize Abbott Lab’s Ferrograd

06-01-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has approved an agreement with the local subsidiary…

Abbott LaboratoriesAsia-PacificFerrogradFinancialHematologyPharmaceutical

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted

03-01-2014

China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

US global share of biomedical research spending declines, as Asia gains

02-01-2014

The USA’s global share of biomedical research spending fell from 51% in 2007 to 45% in 2012, while…

Asia-PacificChinaFinancialNorth AmericaPharmaceuticalRegulationResearchUSA

92 to 116 of 1009 results

Back to top